{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:17:45Z","timestamp":1778581065861,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Royer Biomedical, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-43047-0","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:46:04Z","timestamp":1773902764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sustained elution of amikacin, clindamycin, and vancomycin from a biodegradable cross-linked dextran gel"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5550-4412","authenticated-orcid":false,"given":"Jennifer G.","family":"Barrett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer A.","family":"Raffetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7591-7898","authenticated-orcid":false,"given":"Mark G.","family":"Papich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8964-5264","authenticated-orcid":false,"given":"Kenneth E.","family":"Sullins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"43047_CR1","doi-asserted-by":"publisher","unstructured":"Hrynyshyn, A., Simoes, M. & Borges, A. Biofilms in surgical site infections: recent advances and novel prevention and eradication strategies. Antibiot. (Basel). 11 (1). https:\/\/doi.org\/10.3390\/antibiotics11010069 (2022).","DOI":"10.3390\/antibiotics11010069"},{"issue":"1","key":"43047_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/evj.12564","volume":"49","author":"CM Isgren","year":"2017","unstructured":"Isgren, C. M., Salem, S. E., Archer, D. C., Worsman, F. C. & Townsend, N. B. Risk factors for surgical site infection following laparotomy: effect of season and perioperative variables and reporting of bacterial isolates in 287 horses. Equine Vet. J. 49 (1), 39\u201344 (2017).","journal-title":"Equine Vet. J."},{"issue":"Suppl 1","key":"43047_CR3","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/S0163-4453(09)60006-2","volume":"59","author":"DL Stevens","year":"2009","unstructured":"Stevens, D. L. Treatments for skin and soft-tissue and surgical site infections due to MDR Gram-positive bacteria. J. Infect. 59 (Suppl 1), S32\u2013S39 (2009).","journal-title":"J. Infect."},{"issue":"3","key":"43047_CR4","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s00248-016-0867-9","volume":"73","author":"K Rahim","year":"2017","unstructured":"Rahim, K. et al. Bacterial contribution in chronicity of wounds. Microb. Ecol. 73 (3), 710\u2013721 (2017).","journal-title":"Microb. Ecol."},{"key":"43047_CR5","doi-asserted-by":"publisher","first-page":"1042128","DOI":"10.3389\/fbioe.2022.1042128","volume":"10","author":"Y Liu","year":"2022","unstructured":"Liu, Y., Li, X. & Liang, A. Current research progress of local drug delivery systems based on biodegradable polymers in treating chronic osteomyelitis. Front. Bioeng. Biotechnol. 10, 1042128 (2022).","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"2","key":"43047_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jacc.2022.10.022","volume":"81","author":"M Topaz","year":"2023","unstructured":"Topaz, M. et al. Regional antibiotic delivery for implanted cardiovascular electronic device infections. J. Am. Coll. Cardiol. 81 (2), 119\u2013133 (2023).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"43047_CR7","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1080\/10717544.2021.1998246","volume":"28","author":"RK Wassif","year":"2021","unstructured":"Wassif, R. K., Elkayal, M., Shamma, R. N. & Elkheshen, S. A. Recent advances in the local antibiotics delivery systems for management of osteomyelitis. Drug Deliv. 28 (1), 2392\u20132414 (2021).","journal-title":"Drug Deliv"},{"issue":"6","key":"43047_CR8","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/j.1532-950X.2011.00861.x","volume":"40","author":"LA Thomas","year":"2011","unstructured":"Thomas, L. A., Bizikova, T. & Minihan, A. C. In vitro elution and antibacterial activity of clindamycin, amikacin, and vancomycin from R-gel polymer. Vet. Surg. 40 (6), 774\u2013780 (2011).","journal-title":"Vet. Surg."},{"key":"43047_CR9","doi-asserted-by":"publisher","unstructured":"Steadman, W. et al. Local antibiotic delivery options in prosthetic joint infection. Antibiot. (Basel). 12 (4). https:\/\/doi.org\/10.3390\/antibiotics12040752 (2023).","DOI":"10.3390\/antibiotics12040752"},{"key":"43047_CR10","doi-asserted-by":"publisher","unstructured":"Hu, B., Gao, J., Lu, Y. & Wang, Y. Applications of degradable hydrogels in novel approaches to disease treatment and new modes of drug delivery. Pharmaceutics 15 (10). https:\/\/doi.org\/10.3390\/pharmaceutics15102370 (2023).","DOI":"10.3390\/pharmaceutics15102370"},{"issue":"12","key":"43047_CR11","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.addr.2003.08.007","volume":"55","author":"Z Ruszczak","year":"2003","unstructured":"Ruszczak, Z. & Friess, W. Collagen as a carrier for on-site delivery of antibacterial drugs. Adv. Drug Deliv Rev. 55 (12), 1679\u20131698 (2003).","journal-title":"Adv. Drug Deliv Rev."},{"key":"43047_CR12","doi-asserted-by":"crossref","unstructured":"Bayer, I. S. Hyaluronic acid and controlled release: a review. Molecules 25(11) (2020).","DOI":"10.3390\/molecules25112649"},{"issue":"1","key":"43047_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jconrel.2008.01.006","volume":"128","author":"S Tamilvanan","year":"2008","unstructured":"Tamilvanan, S., Venkateshan, N. & Ludwig, A. The potential of lipid- and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections. J. Controlled Release. 128 (1), 2\u201322 (2008).","journal-title":"J. Controlled Release"},{"issue":"3","key":"43047_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/jbm.a.33207","volume":"99","author":"DE Gerber","year":"2011","unstructured":"Gerber, D. E. et al. A novel polymer gel for the delivery of local therapies to intracranial tumors: in vivo safety evaluation. J. Biomed. Mater. Res. A. 99 (3), 479\u2013484 (2011).","journal-title":"J. Biomed. Mater. Res. A"},{"key":"43047_CR15","unstructured":"Hart, S. K., Sullins, K. E., Brown, J. A., Barrett, J. G. & Papich, M. G. Elution of antibiotics from a novel cross-linked dextran gel (Virginia Polytechnic Institute and State University, 2009)."},{"issue":"8","key":"43047_CR16","doi-asserted-by":"publisher","first-page":"ix","DOI":"10.1046\/j.1469-0691.2003.00790.x","volume":"9","author":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID)","year":"2003","unstructured":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin. Microbiol. Infect. 9 (8), ix\u2013xv (2003).","journal-title":"Clin. Microbiol. Infect."},{"issue":"10","key":"43047_CR17","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.2460\/ajvr.67.10.1687","volume":"67","author":"A Parra-Sanchez","year":"2006","unstructured":"Parra-Sanchez, A. et al. Pharmacokinetics and pharmacodynamics of enrofloxacin and a low dose of amikacin administered via regional intravenous limb perfusion in standing horses. Am. J. Vet. Res. 67 (10), 1687\u20131695 (2006).","journal-title":"Am. J. Vet. Res."},{"issue":"12","key":"43047_CR18","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.2460\/ajvr.2005.66.2107","volume":"66","author":"LM Rubio-Martinez","year":"2005","unstructured":"Rubio-Martinez, L. M. et al. Evaluation of safety and pharmacokinetics of vancomycin after intravenous regional limb perfusion in horses. Am. J. Vet. Res. 66 (12), 2107\u20132113 (2005).","journal-title":"Am. J. Vet. Res."},{"issue":"6","key":"43047_CR19","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1532-950X.2005.00096.x","volume":"34","author":"L Rubio-Martinez","year":"2005","unstructured":"Rubio-Martinez, L. et al. Medullary plasma pharmacokinetics of vancomycin after intravenous and intraosseous perfusion of the proximal phalanx in horses. Vet. Surg. 34 (6), 618\u2013624 (2005).","journal-title":"Vet. Surg."},{"issue":"2","key":"43047_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2460\/ajvr.2004.65.173","volume":"65","author":"HC McKenzie","year":"2004","unstructured":"McKenzie, H. C. 3, Murray, M. J. & rd, Concentrations of gentamicin in serum and bronchial lavage fluid after once-daily aerosol administration to horses for seven days. Am. J. Vet. Res. 65 (2), 173\u2013178 (2004).","journal-title":"Am. J. Vet. Res."},{"issue":"5","key":"43047_CR21","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/vsu.13421","volume":"49","author":"CRM Hagen","year":"2020","unstructured":"Hagen, C. R. M. et al. In vitro elution of amikacin and Dispersin B from a polymer hydrogel. Vet. Surg. 49 (5), 1035\u20131042 (2020).","journal-title":"Vet. Surg."},{"issue":"S1","key":"43047_CR22","first-page":"11","volume":"36","author":"N Vijayakumar","year":"2022","unstructured":"Vijayakumar, N. et al. Effect of formulation on the release kinetics of the antibiotics from biocompatible ceramics. Trends Biomater. Artif. Organs. 36 (S1), 11\u201317 (2022).","journal-title":"Trends Biomater. Artif. Organs"},{"issue":"1","key":"43047_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/AAC.03676-14","volume":"59","author":"RP Howlin","year":"2015","unstructured":"Howlin, R. P. et al. Antibiotic-loaded synthetic calcium sulfate beads for prevention of bacterial colonization and biofilm formation in periprosthetic infections. Antimicrob. Agents Chemother. 59 (1), 111\u2013120 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"43047_CR24","doi-asserted-by":"publisher","unstructured":"Madadi, A. K. & Sohn, M. J. Pharmacokinetic interpretation of applying local drug delivery system for the treatment of deep surgical site infection in the spine. Pharmaceutics 16 (1). https:\/\/doi.org\/10.3390\/pharmaceutics16010094 (2024).","DOI":"10.3390\/pharmaceutics16010094"},{"issue":"Suppl 1","key":"43047_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/jac\/dkg210","volume":"51","author":"R Wise","year":"2003","unstructured":"Wise, R. Maximizing efficacy and reducing the emergence of resistance. J. Antimicrob. Chemother. 51 (Suppl 1), 37\u201342 (2003).","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"43047_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/infdis\/155.1.93","volume":"155","author":"RD Moore","year":"1987","unstructured":"Moore, R. D., Lietman, P. S. & Smith, C. R. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J. Infect. Dis. 155 (1), 93\u201399 (1987).","journal-title":"J. Infect. Dis."},{"issue":"3","key":"43047_CR27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2460\/ajvr.67.3.409","volume":"67","author":"TB Lescun","year":"2006","unstructured":"Lescun, T. B., Ward, M. P. & Adams, S. B. Gentamicin concentrations in synovial fluid and joint tissues during intravenous administration or continuous intra-articular infusion of the tarsocrural joint of clinically normal horses. Am. J. Vet. Res. 67 (3), 409\u2013416 (2006).","journal-title":"Am. J. Vet. Res."},{"issue":"5","key":"43047_CR28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jiac.2015.02.001","volume":"21","author":"E Asin-Prieto","year":"2015","unstructured":"Asin-Prieto, E., Rodriguez-Gascon, A. & Isla, A. Applications of the pharmacokinetic\/pharmacodynamic (PK\/PD) analysis of antimicrobial agents. J. Infect. Chemother. 21 (5), 319\u2013329 (2015).","journal-title":"J. Infect. Chemother."},{"issue":"5","key":"43047_CR29","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.rmclc.2016.08.001","volume":"27","author":"JL Kuti","year":"2016","unstructured":"Kuti, J. L. Optimizing antimicrobial pharmacodynamics: a guide for your stewardship program. Revista M\u00e9dica Cl\u00ednica Las Condes. 27 (5), 615\u2013624 (2016).","journal-title":"Revista M\u00e9dica Cl\u00ednica Las Condes"},{"key":"43047_CR30","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1086\/491712","volume":"42","author":"MJ Rybak","year":"2006","unstructured":"Rybak, M. J. The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin. Infect. Dis. 42, S35\u2013S39 (2006).","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"43047_CR31","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1128\/AAC.01485-12","volume":"57","author":"NE Holmes","year":"2013","unstructured":"Holmes, N. E. et al. Vancomycin AUC\/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia. Antimicrob. Agents Chemother. 57 (4), 1654\u20131663 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5 Suppl 1","key":"43047_CR32","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/j.ajic.2006.05.227","volume":"34","author":"MJ Rybak","year":"2006","unstructured":"Rybak, M. J. Pharmacodynamics: relation to antimicrobial resistance. Am. J. Infect. Control. 34 (5 Suppl 1), S38\u201345 (2006). discussion S64\u201373.","journal-title":"Am. J. Infect. Control"},{"issue":"3","key":"43047_CR33","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1532-950X.2007.00262.x","volume":"36","author":"H Phillips","year":"2007","unstructured":"Phillips, H., Boothe, D. M., Shofer, F., Davidson, J. S. & Bennett, R. A. In vitro elution studies of amikacin and cefazolin from polymethylmethacrylate. Vet. Surg. 36 (3), 272\u2013278 (2007).","journal-title":"Vet. Surg."},{"issue":"6","key":"43047_CR34","first-page":"715","volume":"39","author":"A Atilla","year":"2010","unstructured":"Atilla, A. et al. In vitro elution of amikacin and vancomycin from impregnated plaster of Paris beads. Vet. Surg. 39 (6), 715\u2013721 (2010).","journal-title":"Vet. Surg."},{"issue":"5","key":"43047_CR35","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1128\/AAC.6.5.582","volume":"6","author":"RJ Fass","year":"1974","unstructured":"Fass, R. J., Rotilie, C. A. & Prior, R. B. Interaction of clindamycin and gentamicin in vitro. Antimicrob. Agents Chemother. 6 (5), 582\u2013587 (1974).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"43047_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/jac\/15.1.31","volume":"15","author":"I Brook","year":"1985","unstructured":"Brook, I. & Walker, R. I. Interaction between penicillin, clindamycin or metronidazole and gentamicin against species of clostridia and anaerobic and facultatively anaerobic gram-positive cocci. J. Antimicrob. Chemother. 15 (1), 31\u201337 (1985).","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"43047_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5312\/wjo.v12.i3.119","volume":"12","author":"CE Berberich","year":"2021","unstructured":"Berberich, C. E., Josse, J., Laurent, F. & Ferry, T. Dual antibiotic loaded bone cement in patients at high infection risks in arthroplasty: rationale of use for prophylaxis and scientific evidence. World J. Orthop. 12 (3), 119\u2013128 (2021).","journal-title":"World J. Orthop."},{"issue":"10","key":"43047_CR38","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1128\/AAC.48.10.4016-4019.2004","volume":"48","author":"SA Shelburne","year":"2004","unstructured":"Shelburne, S. A. et al. In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations. Antimicrob. Agents Chemother. 48 (10), 4016\u20134019 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"43047_CR39","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1128\/AAC.01433-10","volume":"55","author":"MA Zeitlinger","year":"2011","unstructured":"Zeitlinger, M. A. et al. Theuretzbacher, protein binding: do we ever learn? Antimicrob. Agents Chemother. 55 (7), 3067\u20133074 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"43047_CR40","first-page":"307","volume":"42","author":"AL Edmunds","year":"2017","unstructured":"Edmunds, A. L. Otiprio: an FDA-approved ciprofloxacin suspension gel for pediatric otitis media with effusion. P T. 42 (5), 307\u2013311 (2017).","journal-title":"P T"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43047-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43047-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43047-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:51:42Z","timestamp":1778579502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43047-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43047"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43047-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable: no animal or human subjects were in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors have provided consent to publish.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"14182"}}